单倍体与错配无关供者造血干细胞移植治疗范可尼贫血:EBMT重型再生障碍性贫血工作组结果
该研究比较了范可尼贫血患者接受HLA错配无关供者(MMUD)或单倍体供者(HD)造血干细胞移植的结局,HD组仅体内T细胞去除者2年OS为80%、EFS为86%,优于MMUD组和HD联合体外去T组,提示未处理移植物HD可能为替代选择。
要点
- HD仅体内去T组2年EFS为86%,优于MMUD组的58%和HD联合体外去T组的56%。
- II-IV级急性GVHD在MMUD组为41%,HD未处理组为40%,HD去T移植物组为17%。
- HD仅体内去T可能作为FA患者无HLA全合供者时的替代移植选择。
核心结论
- 单倍体供者尤其是使用未处理移植物联合仅体内T细胞去除,可能为范可尼贫血患者提供优于MMUD的EFS。
研究设计与样本
- 回顾性比较2000至2018年间EBMT登记的范可尼贫血患者接受MMUD(n=123)或单倍体供者(仅体内去T n=33;体内联合体外去T n=59)造血干细胞移植的结局。
主要发现
- 其他移植相关结局未见差异。
临床怎么用
- 对无HLA全合供者的范可尼贫血患者,可考虑单倍体供者移植,优先选择未处理移植物联合仅体内T细胞去除以改善EFS。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic hematopoietic cell transplantation (HCT) is the only curative option for bone marrow failure or hematopoietic malignant diseases for Fanconi anemia (FA) patients. Although results have improved over the last decades, reaching more than 90% survival when a human leukocyte antigen (HLA)-identical donor is available, alternative HCT donors are still less reported. We compared HCT outcomes using HLA-mismatched unrelated donors (MMUD; n = 123) or haplo-identical donors (HDs), either using only in vivo T cell depletion (n = 33) or T cells depleted in vivo with some type of graft manipulation ex vivo (n = 59) performed for FA between 2000 and 2018. Overall survival (OS) by 24 months was 62% (53-71%) for MMUD, versus 80% (66-95%) for HDs with only in vivo T cell depletion and 60% (47-73%) for HDs with in vivo and ex vivo T cell depletion (p = .22). Event-free survival (EFS) was better for HD-transplanted FA patients with only in vivo T cell depletion 86% (73-99%) than for those transplanted from a MMUD 58% (48-68%) or those with graft manipulation 56% (42-69%) (p = .046). Grade II-IV acute graft-versus-host disease (GVHD) was 41% (MMUD) versus 40% (HDs with no graft manipulation) versus 17% (HDs with T cell depleted graft), (p = .005). No differences were found for the other transplant related outcomes. These data suggest that HDs might be considered as an alternative option for FA patients with better EFS using unmanipulated grafts.
引用
- Zubicaray J, Pagliara D, Sevilla J, et al. Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT. Am J Hematol. 2021. PMID: 33606297. doi:10.1002/ajh.26135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。